Clinical trials
Phase 1 Alzheimer Disease trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 5 |
| 2017 | 2 |
| 2020 | 1 |
| 2024 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 10 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 6 |
| Janssen Pharmaceutical K.K. | 2 |
| Kyowa Kirin Co., Ltd. | 2 |
| Pfizer | 2 |
| Avid Radiopharmaceuticals | 1 |
| Biogen | 1 |
| Chugai Pharmaceutical | 1 |
| Eisai Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 26 |
| Cognitive Dysfunction | 3 |
| Plaque, Amyloid | 3 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Dementia | 1 |
| Mental Disorders | 1 |
| Nervous System Diseases | 1 |
| Neurocognitive Disorders | 1 |
| Neurodegenerative Diseases | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.